KRAS and neoplasm: The well-studied cell-autonomous effects of mutant KRAS conferring addictive proliferation advantages to the tumour cell35, 37 may be complemented by this paracrine axis and may temporally precede its clinical manifestation, since mutant KRAS likely promotes pleural metastasis prior to MPE development18, 19.